StockData

Chemours vs FMC

CC and FMC side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CC and FMC compare

Chemours is the larger company, worth 2.4 times as much as FMC ($2.1B against $877M).

Chemours grew revenue faster over the last twelve months (0.07% versus −22.0% for FMC).

Chemours keeps more of each dollar of sales as profit, with a net margin of −2.6% compared with −151% at FMC.

Both pay dividends: Chemours yields 2.6% and FMC 5.7%.

FMC scores higher on the StockData Score (6 against 5 for Chemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCCFMC
Size and price
Market cap$2.1B$877M
Share price$13.72$5.64
Change, 1 year7.6%−59.7%
Change, 5 years−56.8%−94.6%
Beta (5Y)1.570.80
Employees5,7005,500
StockData Score
Total score56 (better)
Valuation score11
Growth score00
Performance score1 (better)0
Health score11
Dividend score24 (better)
Valuation
P/S0.4×0.3× (better)
P/B13.3×–
EV/EBITDA7.2×–
P/FCF9.8×2.4× (better)
FCF yield10.2%42.2% (better)
Growth
Revenue growth (TTM)0.07% (better)−22.0%
Revenue growth, 5Y average3.2% (better)−5.7%
Profitability
Gross margin15.2%22.0% (better)
Operating margin–−97.0%
Net margin−2.6% (better)−151%
FCF margin3.6%13.1% (better)
Return on equity−71.8% (better)−227%
Return on invested capital–−38.4%
Financial health
Debt / equity24.73–
Net debt / EBITDA4.32–
Interest coverage–−10.0×
Current ratio1.81 (better)1.66
Altman Z-score1.42 (better)−0.19
Piotroski F-score4 (better)2
Dividends and buybacks
Dividend yield2.6%5.7% (better)
Years of dividend growth00
Dividend growth, 5Y average−12.5%0.22% (better)
Buyback yield–−46.0%
Shareholder yield2.6% (better)−40.3%
Ownership
Held by institutions90.2%82.3%
Held by insiders0.96%20.9%
Insider net buying, 12 months$489K (better)$202K
Superinvestors holding–1
Short interest, % of float9.8%31.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.